Engineering of TIMP-3 as a LAP-fusion protein for targeting to sites of inflammation

A comparative study of matrix metalloproteinase and aggrecanase mediated release of latent cytokines at arthritic joints

(2013) Lisa Mullen et al.   ANNALS OF THE RHEUMATIC DISEASES

Latency can be conferred to a variety of cytokines by fusion with latency-associated peptide from TGF-β

(2013) Lisa Mullen et al.   Expert Opinion on Drug Delivery

Latent cytokines for targeted therapy of inflammatory disorders

(2013) Lisa Mullen et al.   Expert Opinion on Drug Delivery

Molecular engineering of short half-life small peptides (VIP, αMSH and γ3MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeutics

(2011) Sandrine Vessillier et al.   ANNALS OF THE RHEUMATIC DISEASES

Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications

(2010) Ngee H. Lim et al.   BIOCHEMICAL JOURNAL

The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3

(2009) Linda Troeberg et al.   MATRIX BIOLOGY